Randomized Controlled Treatment Trial of Irritable Bowel Syndrome with a Probiotic E.-coli Preparation (DSM17252) Compared to Placebo
- Alternative title
-
Eine randomisierte, kontrollierte Behandlungsstudie beim Reizdarmsyndrom mit einer probiotischen E.-coli-Präparation (DSM17252) im Vergleich zu Placebo
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Randomized Controlled Treatment Trial of Irritable Bowel Syndrome with a Probiotic E.-coli Preparation (DSM17252) Compared to Placebo ; volume:52 ; number:01 ; year:2014 ; pages:64-64
Zeitschrift für Gastroenterologie ; 52, Heft 01 (2014), 64-64
- Contributor
-
Enck, P.
Zimmermann, K.
Menke, G.
Klosterhalfen, S.
- DOI
-
10.1055/s-0034-1366796
- URN
-
urn:nbn:de:101:1-2019021110393224543157
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:55 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Enck, P.
- Zimmermann, K.
- Menke, G.
- Klosterhalfen, S.
Other Objects (12)
Irritable bowel syndrome: Is it “irritable brain” or “irritable bowel”?
Effects of probiotic supplementation on post-infectious irritable bowel syndrome in rodent model
Probiotic therapy in patients with irritable bowel syndrome: does it have a real role?
Diet in irritable bowel syndrome
A randomized placebo-controlled clinical trial of a multi-strain probiotic formulation (Bio-Kult®) in the management of diarrhea-predominant irritable bowel syndrome
A candidate probiotic with unfavourable effects in subjects with irritable bowel syndrome: a randomised controlled trial
Effect of a multispecies probiotic supplement on quantity of irritable bowel syndrome-related intestinal microbial phylotypes
A randomised controlled trial of a probiotic ‘functional food’ in the management of irritable bowel syndrome
A double-blind placebo-controlled trial to study therapeutic effects of probiotic Escherichia coli Nissle 1917 in subgroups of patients with irritable bowel syndrome
Efficacy and Safety of the Adjuvant Use of Probiotic Bacillus clausii Strains in Pediatric Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Study
Fecal microbiota profiling in irritable bowel syndrome and inflammatory bowel disease patients with irritable bowel syndrome-type symptoms
Clinical implications of irritable bowel syndrome
Irritable bowel syndrome: Is it “irritable brain” or “irritable bowel”?
Effects of probiotic supplementation on post-infectious irritable bowel syndrome in rodent model
Probiotic therapy in patients with irritable bowel syndrome: does it have a real role?
Diet in irritable bowel syndrome
A randomized placebo-controlled clinical trial of a multi-strain probiotic formulation (Bio-Kult®) in the management of diarrhea-predominant irritable bowel syndrome
A candidate probiotic with unfavourable effects in subjects with irritable bowel syndrome: a randomised controlled trial
Effect of a multispecies probiotic supplement on quantity of irritable bowel syndrome-related intestinal microbial phylotypes
A randomised controlled trial of a probiotic ‘functional food’ in the management of irritable bowel syndrome
A double-blind placebo-controlled trial to study therapeutic effects of probiotic Escherichia coli Nissle 1917 in subgroups of patients with irritable bowel syndrome
Efficacy and Safety of the Adjuvant Use of Probiotic Bacillus clausii Strains in Pediatric Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Study
Fecal microbiota profiling in irritable bowel syndrome and inflammatory bowel disease patients with irritable bowel syndrome-type symptoms
Clinical implications of irritable bowel syndrome
Irritable bowel syndrome: Is it “irritable brain” or “irritable bowel”?
Effects of probiotic supplementation on post-infectious irritable bowel syndrome in rodent model
Probiotic therapy in patients with irritable bowel syndrome: does it have a real role?
Diet in irritable bowel syndrome
A randomized placebo-controlled clinical trial of a multi-strain probiotic formulation (Bio-Kult®) in the management of diarrhea-predominant irritable bowel syndrome
A candidate probiotic with unfavourable effects in subjects with irritable bowel syndrome: a randomised controlled trial
Effect of a multispecies probiotic supplement on quantity of irritable bowel syndrome-related intestinal microbial phylotypes
A randomised controlled trial of a probiotic ‘functional food’ in the management of irritable bowel syndrome
A double-blind placebo-controlled trial to study therapeutic effects of probiotic Escherichia coli Nissle 1917 in subgroups of patients with irritable bowel syndrome
Efficacy and Safety of the Adjuvant Use of Probiotic Bacillus clausii Strains in Pediatric Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Study
Fecal microbiota profiling in irritable bowel syndrome and inflammatory bowel disease patients with irritable bowel syndrome-type symptoms